District Business Manager- Hematology at Bristol-Myers Squibb

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Ability to lead a team of highly motivated sales professionals by creating and articulating a vision for the district aligned with organizational objectives
Skills to effectively analyze performance data, market trends, market access dynamics, and build strategic business plans to address challenges and capitalize on opportunities
Clear and thorough understanding of BMS Hematology products, the Hematology marketplace, relevant competitive products, and the disease area
Ability to leverage product and disease state knowledge to model and coach the team on exemplary selling skills
Capacity to actively facilitate the growth and development of team members based on their needs, motivation, and business requirements
Ability to create an environment of continuous learning where team members feel challenged and engaged
Proficiency in leading a group through change while maintaining focus on current and future business needs
Compliance with all laws, regulations, and policies that govern the role

Responsibilities

Lead a team of motivated sales professionals, providing approved disease and product information and resources to key decision makers and stakeholders
Inspire and motivate the team to reach and exceed business goals while maximizing their growth and development potential
Report to the Regional Business Director and collaborate across a matrix sales organization to address customer needs, deliver on sales targets, and demonstrate value to customers

Skills

Pharmaceutical Sales

Hematology

Oncology

Sales Management

Leadership

Immunotherapies

Cancer Therapies

Business Development

Account Management

Healthcare Sales

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free